cART and Supportive Care for HIV-Associated Malignancies
cART is an abbreviation for combined antiretroviral therapy and generally refers to a three- or four-drug combination regimen of antiretroviral medications, which is considered standard treatment for human immunodeficiency virus-1 (HIV-1) infection. Another name for cART is highly active antiretroviral therapy (HAART). This treatment is important for suppressing HIV-1 replication and has greatly increased the longevity of individuals with this infection. As part of the treatment of malignancies in HIV-infected patients, cART and other supportive measures such as antiemetics, hematopoietic growth factors, blood transfusions, prophylactic and therapeutic antibiotics, antidiarrheal medications, and psychosocial support for each individual undergoing the stressful therapy for these often life-threatening cancers have greatly enhanced both the efficacy and tolerability of these treatments and allowed patients to achieve remissions and/or cure of their cancers.
cART as Treatment...
KeywordsAcquire Immune Deficiency Syndrome Hematopoietic Growth Factor Myelosuppressive Effect Routine Screening Procedure Reduce Cancer Health Disparity
- Hymes KB, Cheung T, Greene JB, Prose NS, Marcus A, Ballard H, William DC, Laubenstein W. Kaposi’s sarcoma in homosexual men – a report of 8 cases. Lancet. 1981;2(8248):688.Google Scholar
- Kaplan LD, Kahn JO, Crowe S, et al. Clinical and viral effects of recombinant GM-CSF in patients receiving chemotherapy for HIV-associated non-Hodgkin’s lymphoma: results of a randomized trial. J Clin Oncol. 1994;9(6):929–40.Google Scholar
- Moss AR, McCallum G, Volberding PA, Bacchetti P, Dretz S. Mortality associated with mode of presentation in the acquired immunodeficiency syndrome. J Natl Cancer Inst. 1984;23(6):1281–4.Google Scholar